Advanced Search

Study Preview



Study Title and Description

ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV.



Key Questions Addressed
7 Key Question 7. What is the effectiveness of currently recommended antiviral treatments in achieving a SVR in patients with HCV infection?
  • Comments Comments (
    0
    ) |
8 Key Question 8. What are the harms of currently recommended antiviral treatments?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV.
Author Ferenci P., Bernstein D., Lalezari J., Cohen D., Luo Y., Cooper C., Tam E., Marinho RT., Tsai N., Nyberg A., Box TD., Younes Z., Enayati P., Green S., Baruch Y., Bhandari BR., Caruntu FA., Sepe T., Chulanov V., Janczewska E., Rizzardini G., Gervain J., Planas R., Moreno C., Hassanein T., Xie W., King M., Podsadecki T., Reddy KR.
Country The authors' affiliations are listed in the Appendix.
Year 2014
Numbers Pubmed ID: 24795200

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-9


Results & Comparisons

No Results found.